Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.
By Mill Chart
Last update: Mar 27, 2024
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Today's pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| SYK | 22.05% | STRYKER CORP's (NYSE:SYK) shares rose 22.05% to $427.64. In the last 6 months the stock gained 28.22%. |
| CTAS | 4.81% | Investors witnessed a remarkable surge in CINTAS CORP (NASDAQ:CTAS) during Wednesday's pre-market session, with the stock price rising 4.81% to $663.85. yesterday the company released their earnings. A press release (Cintas Corporation Announces Fiscal 2024 Third Quarter Results) was released earlier today. |
| MRK | 3.97% | Investors witnessed a remarkable surge in MERCK & CO. INC. (NYSE:MRK) during Wednesday's pre-market session, with the stock price rising 3.97% to $130.5. Yesterday the company had a press release: FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1). |
| WDC | 2.33% | During Wednesday's pre-market session, WESTERN DIGITAL CORP (NASDAQ:WDC) experienced a 2.33% increase, with the stock price reaching $69.74. In the last 3 months the stock gained 30.13%. |
| CEG | 2.32% | During Wednesday's pre-market session, CONSTELLATION ENERGY (NASDAQ:CEG) experienced a 2.32% increase, with the stock price reaching $189.72. The stock is trading 58.62% higher than 3 months ago. |
| MRNA | 2.27% | MODERNA INC's (NASDAQ:MRNA) stock price increased by 2.27% to $109.85. The stock is trading 30.06% lower than a year ago. |
| SMCI | 2.24% | Exciting news for SUPER MICRO COMPUTER INC (NASDAQ:SMCI) as their shares soared 2.24% to $1.05K during the pre-market session on Wednesday. Yesterday the company had a press release: Super Micro Computer, Inc. (SMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings. |
| TSLA | 2.13% | Pre-market trading on Wednesday showed positive momentum for TESLA INC (NASDAQ:TSLA), as the stock price advanced 2.13% to reach $181.45. A press release (Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?) was released yesterday. |
Our premarket gainers page will show you the full list.
MERCK & CO. INC.
NYSE:MRK (4/19/2024, 7:04:59 PM)
After market: 125.4 -0.38 (-0.3%)125.78
+0.55 (+0.44%)
MRK News
2 days ago - Merck Canada Inc.Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and/CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab),...
4 days ago - InvestorPlaceComing FDA Approvals Could Send These 3 Drug Stocks SoaringWhen it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.
5 days ago - InvestorPlace3 Dow Stocks to Buy Now: Q2 EditionAlthough the idea of Dow stocks to buy now is patently boring, that could be a positive attribute amid the current backdrop.
6 days ago - The Motley FoolBetter Growth Play: Merck or The Vanguard Growth Index Fund?Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
7 days ago - The Motley FoolMerck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.Being able to stop a drug's unwanted effects could lead to a larger market share.
9 days ago - The Motley Fool1 New Green Flag for Moderna and Merck StockThere's a new reason to believe that their joint projects are going well.
9 days ago - InvestorPlace7 A-Rated Aggressive Biotech Stocks to Bet On in 2024We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.
10 days ago - Market News VideoSee Which Of The Latest 13F Filers Holds Merck & Co
10 days ago - InvestorPlaceThe $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% TodayVertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
10 days ago - ChartmillWhen you look at NYSE:MRK, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.MERCK & CO. INC. (NYSE:MRK): good value for what you're paying.
11 days ago - Market News VideoMRK December 2026 Options Begin Trading13 days ago - Market News VideoMonday Sector Laggards: Energy, Healthcare
